Publisher Correction: Hypoblast from human pluripotent stem cells regulates epiblast development

Nature. 2024 Feb;626(8001):E21. doi: 10.1038/s41586-024-07166-w.

Takumi Okubo¹, Nicolas Rivron², Mio Kabata¹, Hideki Masaki^{3

4}, Keiko Kishimoto⁵, Katsunori Semi¹, May Nakajima-Koyama¹, Haruko Kunitomi¹, Belinda Kaswandy¹, Hideyuki Sato^{3

4}, Hiromitsu Nakauchi^{3

4

6}, Knut Woltjen¹, Mitinori Saitou^{1

7

8}, Erika Sasaki⁵, Takuya Yamamoto^{9

10

11}, Yasuhiro Takashima¹²

¹ Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
² Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
³ Institute of Medical Science, University of Tokyo, Tokyo, Japan.
⁴ Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
⁵ Central Institute for Experimental Animals, Kawasaki, Japan.
⁶ Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
⁷ Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
⁸ Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁹ Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan. [email protected].
¹⁰ Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. [email protected].
¹¹ Medical-risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan. [email protected].
¹² Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan. [email protected].

No abstract available

Publication types